ReviewCureus2024

Assessment of the Efficacy and Safety of Acalabrutinib in Chronic Lymphocytic Leukemia (CLL): A Systematic Review and Meta‑Analysis .

Rashad Q OthmanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.